Zimmer Biomet Holdings Inc (ZBH) - Total Assets
Based on the latest financial reports, Zimmer Biomet Holdings Inc (ZBH) holds total assets worth $23.49 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Zimmer Biomet Holdings Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Zimmer Biomet Holdings Inc - Total Assets Trend (1999–2024)
This chart illustrates how Zimmer Biomet Holdings Inc's total assets have evolved over time, based on quarterly financial data. Explore ZBH long-term investments to assets to see how much of total assets are deployed in long-term investments.
Zimmer Biomet Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Zimmer Biomet Holdings Inc's total assets of $23.49 Billion consist of 21.9% current assets and 78.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $525.50 Million | 2.5% |
| Accounts Receivable | $1.48 Billion | 6.9% |
| Inventory | $2.24 Billion | 10.5% |
| Property, Plant & Equipment | $2.26 Billion | 10.6% |
| Intangible Assets | $4.60 Billion | 21.5% |
| Goodwill | $8.95 Billion | 41.9% |
Asset Composition Trend (1999–2024)
This chart illustrates how Zimmer Biomet Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Zimmer Biomet Holdings Inc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zimmer Biomet Holdings Inc's current assets represent 21.9% of total assets in 2024, a decrease from 71.0% in 1999.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2024, up from 0.0% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 0.0% in 1999.
- Asset Diversification: The largest asset category is goodwill at 41.9% of total assets.
Zimmer Biomet Holdings Inc Competitors by Total Assets
Key competitors of Zimmer Biomet Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
|
China | CN¥3.54 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
Zimmer Biomet Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.43 | 1.36 | 1.99 |
| Quick Ratio | 1.39 | 0.70 | 1.03 |
| Cash Ratio | 0.00 | 0.16 | 0.00 |
| Working Capital | $3.43 Billion | $1.29 Billion | $2.53 Billion |
Zimmer Biomet Holdings Inc - Advanced Valuation Insights
This section examines the relationship between Zimmer Biomet Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.43 |
| Latest Market Cap to Assets Ratio | 0.83 |
| Asset Growth Rate (YoY) | -0.6% |
| Total Assets | $21.37 Billion |
| Market Capitalization | $17.70 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Zimmer Biomet Holdings Inc's assets close to their book value (0.83x), suggesting investors view the company's assets at approximately fair value.
Slight Asset Contraction: Zimmer Biomet Holdings Inc's assets decreased by 0.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Zimmer Biomet Holdings Inc (1999–2024)
The table below shows the annual total assets of Zimmer Biomet Holdings Inc from 1999 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $21.37 Billion | -0.61% |
| 2023-12-31 | $21.50 Billion | +2.05% |
| 2022-12-31 | $21.07 Billion | -10.19% |
| 2021-12-31 | $23.46 Billion | -3.94% |
| 2020-12-31 | $24.42 Billion | -0.90% |
| 2019-12-31 | $24.64 Billion | +2.12% |
| 2018-12-31 | $24.13 Billion | -7.25% |
| 2017-12-31 | $26.01 Billion | -2.51% |
| 2016-12-31 | $26.68 Billion | -2.64% |
| 2015-12-31 | $27.41 Billion | +184.48% |
| 2014-12-31 | $9.63 Billion | +0.56% |
| 2013-12-31 | $9.58 Billion | +6.30% |
| 2012-12-31 | $9.01 Billion | +5.84% |
| 2011-12-31 | $8.52 Billion | +6.44% |
| 2010-12-31 | $8.00 Billion | +2.75% |
| 2009-12-31 | $7.79 Billion | +7.55% |
| 2008-12-31 | $7.24 Billion | +9.12% |
| 2007-12-31 | $6.63 Billion | +11.04% |
| 2006-12-31 | $5.97 Billion | +4.41% |
| 2005-12-31 | $5.72 Billion | +0.46% |
| 2004-12-31 | $5.70 Billion | +10.46% |
| 2003-12-31 | $5.16 Billion | +500.30% |
| 2002-12-31 | $858.90 Million | +15.29% |
| 2001-12-31 | $745.00 Million | +24.71% |
| 2000-12-31 | $597.40 Million | -1.42% |
| 1999-12-31 | $606.00 Million | -- |
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skul… Read more